The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer.
Yael BarKfir BarDidi FeldmanJudith Ben- DrorMeishar ShahohaShir LernerShlomit Strulov ShacharAhuva Weiss-MeilikNachum DershowitzIdo WolfAmir SonnenblickPublished in: Breast (Edinburgh, Scotland) (2024)
In early HR + HER2- IDC, an EIC correlates with a reduced genomic recurrence risk. The impact on genomic risk seems to be influenced by the extent, not merely the presence, of DCIS.